Carelane Raises €800,000 in Pre-Seed Funding to Revolutionize Clinical Trial Software

New York, June 1st, 2024 — We are excited to announce the successful closure of our pre-seed funding round, raising €800,000. The investment, led by High-Tech Gründerfonds (HTGF), will fuel the expansion of our unified platform designed to streamline clinical trials, significantly reducing the operational burdens faced by pharmaceutical companies, contract research organizations, and academic researchers.

Clinical trials today face inefficiencies and high costs because they are reliant on multiple disjointed software systems for essential tasks such as data management, eConsent, tokenization, sample tracking, drug supply, and patient follow-up. The time required for integration and the challenges of process orchestration, along with regulatory compliance demands for unified audit trails, further complicate the situation.

Carelane uniquely integrates these features into a single platform, significantly reducing the complexity and expense associated with traditional clinical trial management. With Carelane, study protocols are structured, digitized documents rather than text-based, enabling seamless integration and continuous alignment of study design, conduct, and analysis. This approach avoids costly amendments that can cost millions of dollars.

Our platform not only enhances security using the latest cloud technologies but also includes features for managing common trial processes such as sample shipments, site onboarding, and patient consents. All of this is achieved while maintaining a unified audit trail.

With this new capital, we will broaden our reach across Europe and the United States. We were able to demonstrate substantial traction before this funding round by reducing trial management burden by more than 80% for our initial customer through enhanced collaboration features and process automation. Looking ahead, we plan to expand our platform with source data capture capabilities, including automatic data ingestion from electronic health records (EHRs) and AI features, setting the stage for a forthcoming seed funding round.

‍

Read more here: https://www.htgf.de/en/htgf-pre-seed-carelane/